Cite

HARVARD Citation

    Roth, A. (2022). New Drug Modalities Demand a Refined Preclinical Safety Assessment: A Call for Patient-Relevant Tissue Models. Toxicological sciences. pp. 5-6. [Online]. 
  
Back to record